M&A Deal Summary

Baxter International Acquires Sigma International General Medical Apparatus

On April 25, 2012, Baxter International, Inc. acquired medical products company Sigma International General Medical Apparatus LLC from Lovett Miller & Co. for 259M USD

Acquisition Highlights
  • This is Baxter International’s 5th transaction in the Medical Products sector.
  • This is Baxter International’s 9th largest (disclosed) transaction.
  • This is Baxter International’s 9th transaction in the United States.
  • This is Baxter International’s 1st transaction in New York.

M&A Deal Summary

Date 2012-04-25
Target Sigma International General Medical Apparatus LLC
Sector Medical Products
Buyer(s) Baxter International, Inc.
Sellers(s) Lovett Miller & Co.
Deal Type Add-on Acquisition
Deal Value 259M USD

Target

Sigma International General Medical Apparatus LLC

Medina, New York, United States
website
Designs and Manufactures Smart Infusion Pumps for Hospitals.

Search 159,180 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Baxter International, Inc.

Deerfield, Illinois, United States

website


Category Company
Founded 1931
SectorMedical Products
Employees50,000
Revenue 11.7B USD (2020)
DESCRIPTION
Entrance to Baxter International's corporate headquarters in Deerfield, Illinois.
Entrance to Baxter International's corporate headquarters in Deerfield, Illinois.

Baxter International develops, manufactures and markets drugs and medical products for people with a variety of medical conditions. Baxter's operations are comprised of the BioScience and Medical Products segments. The BioScience business processes recombinant and plasma-based proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies, alpha-1 antitrypsin deficiency, burns and shock, and other chronic and acute blood-related conditions; biosurgery products; and select vaccines. The Medical Products business manufactures intravenous (IV) solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, infusion pumps, and inhalation anesthetics. The business also provides products and services related to pharmacy compounding, drug formulation and packaging technologies. In addition, the Medical Products business provides products and services to treat end-stage renal disease, or irreversible kidney failure. Baxter International was founded in 1931 and is based in Deerfield, Illinois.


DEAL STATS #
Overall 10 of 20
Sector (Medical Products) 5 of 12
Type (Add-on Acquisition) 8 of 14
State (New York) 1 of 1
Country (United States) 9 of 14
Year (2012) 2 of 2
Size (of disclosed) 9 of 17
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2012-02-14 Synovis Life Technologies, Inc.

St Paul, Minnesota, United States

Synovis Life Technologies, Inc., a diversified medical device company based in St. Paul, Minn., develops, manufactures and markets biological and mechanical products used by several surgical specialties to facilitate the repair and reconstruction of soft tissue damaged or destroyed by disease or injury. The company's products include implantable biomaterials for soft tissue repair, devices for microsurgery and surgical tools - all designed to reduce risks and/or facilitate critical surgeries, improve patient outcomes and reduce healthcare costs.

Buy $325M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2013-09-06 Gambro AB

Stockholm, Sweden

Gambro is a global medical technology company and a leader in developing, manufacturing and supplying products, therapies and services for In-center Care and Self Care hemodialysis, Peritoneal Dialysis, Renal Intensive Care and Hepatic Care. Gambro was founded in 1964 and has more than 8,000 employees, production facilities in 11 countries, sales subsidiaries in more than 40 and sales in more than 100 countries.

Buy $3.9B

Seller(S) 1

SELLER

Lovett Miller & Co.

Neptune Beach, Florida, United States

Investor Investor

website


Category Private Equity Firm
Founded 1997
PE ASSETS 175M USD
SizeSmall
Type Sector Agnostic
DESCRIPTION

Lovett Miller & Co. is a private equity firm that provides growth and shareholder liquidity capital to high-growth privately held companies located in the Southeast US and Texas. Lovett Miller looks for businesses generating sales of $1 to $50 million and can commit up to $15 million per transaction. Areas of interest include technology products and services, healthcare services and devices, business services, consumer and retail, and financial services. The Firm prefers minority positions. Lovett Miller is based in Jacksonville, Florida with an additional office in Tampa.


DEAL STATS #
Overall 11 of 17
Sector (Medical Products) 2 of 2
Type (Add-on Acquisition) 7 of 11
State (New York) 1 of 1
Country (United States) 11 of 17
Year (2012) 1 of 5
Size (of disclosed) 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2010-11-08 Kinetic Books Company, Inc.

Seattle, Washington, United States

Kinetic Books Company, Inc., an interactive textbook publisher, creates and publishes digital curriculum products.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2012-05-03 TIAA Bank

Jacksonville, Florida, United States

TIAA Bank provides full-service, nationwide banking and lending services to consumer, commercial and institutional clients through a variety of channels, including online, its Florida-based financial centers and at other business offices throughout the country.

Sell -